Stockscreener 앱 받기
1.0199
2.45%
0.0292
전일 마감가:
$0.9907
열려 있는:
$0.9902
하루 거래량:
282.23K
Relative Volume:
0.04
시가총액:
$59.36M
수익:
$950.10K
순이익/손실:
$-16.69M
주가수익비율:
-1.2288
EPS:
-0.83
순현금흐름:
$-15.16M
1주 성능:
+33.75%
1개월 성능:
+60.25%
6개월 성능:
-2.40%
1년 성능:
-4.25%
1일 변동 폭
$0.99
$1.02
1주일 범위
$0.7903
$1.04
52주 변동 폭
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
명칭
Femasys Inc
전화
770-500-3910
주소
3950 JOHNS CREEK COURT, SUWANEE
FEMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
1.015 | 57.94M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
579.02 | 205.21B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.78 | 56.03B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
79.88 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
255.98 | 37.34B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
279.99 | 20.20B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | Laidlaw | Buy |
Femasys Inc 주식(FEMY)의 최신 뉴스
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com UK
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Canada
PharmaCyte Biotech (Nasdaq: PMCB) Now Holds ~$20M Cash, $25M in Marketable Securities - Stock Titan
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential By Investing.com - Investing.com South Africa
Femasys initiated with a Buy at Laidlaw - TipRanks
Why retail investors pile into Femasys Inc. stockJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Is Femasys Inc. stock oversold or undervaluedJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential - Investing.com
Is Femasys Inc. stock attractive for growth ETFsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
What margin trends mean for Femasys Inc. stockRate Hike & Fast Exit Strategy with Risk Control - newser.com
Femasys Inc. (FEMY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Femasys Inc. stock affected by interest rate hikesInsider Buying & Verified Entry Point Detection - newser.com
[Form 4] FEMASYS INC Insider Trading Activity - Stock Titan
Applying Elliott Wave Theory to Femasys Inc.2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Femasys: Strategic Advancements and Financial Health Justify Buy Rating - TipRanks
MSN Money - MSN
Can Femasys Inc. stock reach $100 price targetMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Is Femasys Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Custom watchlist performance reports with Femasys Inc.Earnings Growth Summary & Daily Entry Point Trade Alerts - newser.com
Is Femasys Inc. stock a safe haven assetMarket Performance Report & Reliable Entry Point Alerts - newser.com
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
Will Femasys Inc. stock continue upward momentumPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
What Wall Street predicts for Femasys Inc. stock priceWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Is Femasys Inc. forming a bottoming baseWeekly Loss Report & Free Real-Time Market Sentiment Alerts - newser.com
Combining machine learning predictions for Femasys Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
Applying Wyckoff theory to Femasys Inc. stockQuarterly Portfolio Review & Reliable Entry Point Alerts - newser.com
Does Femasys Inc. show high probability of reboundQuarterly Profit Summary & Smart Money Movement Alerts - newser.com
Femasys Rises On FemBloc Success And Global Expansion Plans - Finimize
Femasys Announces Third Quarter Financial Results for 2025 - The Manila Times
Femasys Q3 sales rise, driven by FemBloc sales - MarketScreener
Femasys Inc (FEMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):